Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Imatinib in Metastatic Renal Cell Carcinoma
NCT00323791Phase 2Terminated
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Apr 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in renal cell carcinoma (RCC), sponsored by University of Medicine and Dentistry of New Jersey. Started Apr 2006; status: terminated.
02
Drugs
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00323791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323791.